Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
$2.81
$1.55
$5.24
$13.46M2.03114,400 shs371,516 shs
Avinger, Inc. stock logo
AVGR
Avinger
$3.86
+0.5%
$3.47
$2.50
$18.00
$6.12M1.2241,220 shs3,042 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.49
+2.1%
$0.47
$0.37
$1.44
$2.39M0.41334,579 shs17,696 shs
Endologix, Inc. stock logo
ELGX
Endologix
$0.07
$0.03
$0.22
$7.10
$1.41M0.731.28 million shs85,372 shs
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
$0.00
$0.00
$0.00
N/A-1.95N/AN/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
0.00%0.00%0.00%0.00%0.00%
Avinger, Inc. stock logo
AVGR
Avinger
+0.52%+0.40%+2.00%+39.19%-50.57%
Dynatronics Co. stock logo
DYNT
Dynatronics
+2.32%+0.06%+23.86%-0.61%-65.49%
Endologix, Inc. stock logo
ELGX
Endologix
0.00%0.00%0.00%0.00%0.00%
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
0.00%0.00%0.00%-80.00%-92.86%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A
Avinger, Inc. stock logo
AVGR
Avinger
2.186 of 5 stars
3.55.00.00.00.60.80.6
Dynatronics Co. stock logo
DYNT
Dynatronics
0.8317 of 5 stars
3.03.00.00.00.60.00.6
Endologix, Inc. stock logo
ELGX
Endologix
N/AN/AN/AN/AN/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
N/AN/AN/AN/A
Avinger, Inc. stock logo
AVGR
Avinger
3.00
Buy$5.0029.68% Upside
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80675.53% Upside
Endologix, Inc. stock logo
ELGX
Endologix
N/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/A

Current Analyst Ratings

Latest ALQA, AVGR, HDII, DYNT, and ELGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2024
Avinger, Inc. stock logo
AVGR
Avinger
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
$2.22M0.00N/AN/A$1.65 per share0.00
Avinger, Inc. stock logo
AVGR
Avinger
$7.65M0.80N/AN/A($4.53) per share-0.85
Dynatronics Co. stock logo
DYNT
Dynatronics
$40.61M0.06N/AN/A$2.19 per share0.22
Endologix, Inc. stock logo
ELGX
Endologix
$143.37M0.01N/AN/A$3.56 per share0.02
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
-$8.42MN/A0.00N/AN/A-230.50%-71.73%-55.23%N/A
Avinger, Inc. stock logo
AVGR
Avinger
-$18.32M-$26.34N/AN/AN/A-239.41%N/A-106.16%5/15/2024 (Confirmed)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%N/A
Endologix, Inc. stock logo
ELGX
Endologix
-$64.76M-$2.19N/AN/AN/A-44.65%-63.96%-13.26%N/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest ALQA, AVGR, HDII, DYNT, and ELGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2024N/A
Avinger, Inc. stock logo
AVGR
Avinger
-$1.35N/A+$1.35N/AN/AN/A  
3/20/2024Q4 2023
Avinger, Inc. stock logo
AVGR
Avinger
$0.64-$3.93-$4.57-$3.93$2.52 million$1.91 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
N/AN/AN/AN/AN/A
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Endologix, Inc. stock logo
ELGX
Endologix
N/AN/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
N/A
8.28
8.17
Avinger, Inc. stock logo
AVGR
Avinger
N/A
0.63
0.36
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
Endologix, Inc. stock logo
ELGX
Endologix
0.29
0.39
0.28
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
13.40%
Avinger, Inc. stock logo
AVGR
Avinger
18.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Endologix, Inc. stock logo
ELGX
Endologix
51.61%
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/A

Insider Ownership

CompanyInsider Ownership
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
13.20%
Avinger, Inc. stock logo
AVGR
Avinger
11.40%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
Endologix, Inc. stock logo
ELGX
Endologix
1.30%
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
40.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alliqua Biomedical Inc stock logo
ALQA
Alliqua Biomedical
65.01 millionN/ANot Optionable
Avinger, Inc. stock logo
AVGR
Avinger
681.59 million1.41 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
Endologix, Inc. stock logo
ELGX
Endologix
52819.17 millionN/AOptionable
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
2,017N/AN/ANot Optionable

ALQA, AVGR, HDII, DYNT, and ELGX Headlines

SourceHeadline
Dietary changes may treat pulmonary hypertensionDietary changes may treat pulmonary hypertension
sciencedaily.com - May 3 at 8:48 PM
The Nurses Role and Skills in Hypertension CareThe Nurse's Role and Skills in Hypertension Care
medscape.com - April 15 at 8:24 PM
Hypertensive disorders of pregnancy increase risk of cardiovascular death after giving birth, study findsHypertensive disorders of pregnancy increase risk of cardiovascular death after giving birth, study finds
msn.com - April 11 at 6:29 PM
Effect of the Dietary Approaches to Stop Hypertension Diet and Reduced Sodium Intake on Blood Pressure ControlEffect of the Dietary Approaches to Stop Hypertension Diet and Reduced Sodium Intake on Blood Pressure Control
medscape.com - March 14 at 7:21 PM
Prevalence of self-reported hypertension 30 percent in 2017 to 2021Prevalence of self-reported hypertension 30 percent in 2017 to 2021
medicalxpress.com - March 12 at 7:14 PM
Why Is Hypertension More Common in African Americans?Why Is Hypertension More Common in African Americans?
medscape.com - March 4 at 7:33 PM
Alcohol Consumption and HypertensionAlcohol Consumption and Hypertension
medscape.com - February 27 at 12:43 PM
Understanding the role played by HIV in pulmonary hypertensionUnderstanding the role played by HIV in pulmonary hypertension
msn.com - February 23 at 10:43 PM
Zofenopril Versus Lisinopril in the Treatment of Essential Hypertension in Elderly PatientsZofenopril Versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients
medscape.com - February 19 at 10:24 AM
Antihypertensive Combos Recommended for BTKi-Linked HypertensionAntihypertensive Combos Recommended for BTKi-Linked Hypertension
physiciansweekly.com - February 19 at 10:24 AM
The Influence of Self-owned Home Blood Pressure Monitoring (HBPM) on Primary Care Patients With HypertensionThe Influence of Self-owned Home Blood Pressure Monitoring (HBPM) on Primary Care Patients With Hypertension
medscape.com - February 7 at 7:25 PM
Treatment of Hypertension in DiabetesTreatment of Hypertension in Diabetes
medscape.com - February 5 at 3:01 PM
What Is Pulmonary Hypertension?What Is Pulmonary Hypertension?
msn.com - January 28 at 9:49 AM
Risk factor control may modify link between HIV status and heart diseaseRisk factor control may modify link between HIV status and heart disease
medicalxpress.com - January 23 at 9:50 PM
Monogenic Forms of Low-Renin HypertensionMonogenic Forms of Low-Renin Hypertension
medscape.com - January 4 at 1:07 PM
Fundamentals of Management of Acute Postoperative Pulmonary HypertensionFundamentals of Management of Acute Postoperative Pulmonary Hypertension
medscape.com - December 15 at 4:07 PM
Hypertension in PregnancyHypertension in Pregnancy
cambridge.org - December 13 at 9:47 AM
High remote patient monitoring practices offer improved hypertension careHigh remote patient monitoring practices offer improved hypertension care
medicalxpress.com - November 7 at 3:32 PM
Correlation between the HALP Score and left ventricular hypertrophy in older patients with hypertensionCorrelation between the HALP Score and left ventricular hypertrophy in older patients with hypertension
medicalxpress.com - November 7 at 3:32 PM
Novo Nordisk buys hypertension drug for $1.3 billionNovo Nordisk buys hypertension drug for $1.3 billion
cen.acs.org - November 4 at 11:32 PM
Improving Hypertension Care for Underserved Populations with Remote Patient MonitoringImproving Hypertension Care for Underserved Populations with Remote Patient Monitoring
medcitynews.com - October 31 at 10:26 PM
Treatment of Hypertension in African Americans and Latinos: The Effect of JNC VI on Urban Prescribing PracticesTreatment of Hypertension in African Americans and Latinos: The Effect of JNC VI on Urban Prescribing Practices
medscape.com - October 29 at 5:39 PM
Managing Hypertension in Patients With Type 2 Diabetes MellitusManaging Hypertension in Patients With Type 2 Diabetes Mellitus
medscape.com - October 17 at 12:39 AM
The Natural Treatment of HypertensionThe Natural Treatment of Hypertension
medscape.com - October 12 at 1:49 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alliqua Biomedical logo

Alliqua Biomedical

NASDAQ:ALQA
Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.
Avinger logo

Avinger

NASDAQ:AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Endologix logo

Endologix

NASDAQ:ELGX
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Hypertension Diagnostics logo

Hypertension Diagnostics

OTCMKTS:HDII
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.